IMPLEMENTATION STATUS OF COST-EFFECTIVE VACCINES IN GAVI-ELIGIBLE COUNTRIES

被引：0
|
作者：
Anderson, J. E. [1 ]
Thorat, T. [1 ]
Neumann, P. J. [1 ]
Cohen, J. T. [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN62
引用
收藏
页码：A82 / A82
页数：1
相关论文
共 50 条
  • [1] Cost effectiveness of child pneumococcal conjugate vaccination in GAVI-eligible countries
    Tasslimi, Azadeh
    Nakamura, Mari M.
    Levine, Orin
    Knoll, Maria D.
    Russell, Louise B.
    Sinha, Anushua
    [J]. INTERNATIONAL HEALTH, 2011, 3 (04): : 259 - 269
  • [2] Study highlights cost-effectiveness and life-saving potential of pneumococcal vaccines in GAVI-eligible countries
    Parker, Edward
    [J]. EXPERT REVIEW OF VACCINES, 2012, 11 (01) : 13 - 13
  • [3] COST-EFFECTIVENESS OF TYPHOID CONJUGATE VACCINE STRATEGIES IN 54 GAVI-ELIGIBLE COUNTRIES
    Bilcke, Joke
    Antillon, Marina
    Pieters, Zoe
    Kuylen, Elise
    Paltiel, A.
    Neuzil, Kathleen
    Pollard, Andrew
    Pitzer, Virginia
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 425 - 426
  • [4] Health and economic impact of rotavirus vaccination in GAVI-eligible countries
    Kim, Sun-Young
    Sweet, Steve
    Slichter, David
    Goldie, Sue J.
    [J]. BMC PUBLIC HEALTH, 2010, 10
  • [5] Health and economic impact of rotavirus vaccination in GAVI-eligible countries
    Sun-Young Kim
    Steve Sweet
    David Slichter
    Sue J Goldie
    [J]. BMC Public Health, 10
  • [6] Characteristics of inpatient and outpatient respiratory syncytial virus mortality in Gavi-eligible countries
    Willemsen, Joukje E.
    Vernooij, Femke S.
    Shaaban, Farina L.
    Chikoti, Chilufya
    Bont, Louis J.
    Drylewicz, Julia
    RSV GOLD Study Grp, R. S. V. G. O. L. D. study group
    [J]. VACCINE: X, 2024, 20
  • [7] Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030
    Atherly, Deborah E.
    Lewis, Kristen D. C.
    Tate, Jacqueline
    Parashar, Umesh D.
    Rheingans, Richard D.
    [J]. VACCINE, 2012, 30 : A7 - A14
  • [8] Choosing the optimalHPVvaccine: The health impact and economic value of the nonavalent and bivalentHPVvaccines in 48 Gavi-eligible countries
    Burger, Emily A.
    Portnoy, Allison
    Campos, Nicole G.
    Sy, Stephen
    Regan, Catherine
    Kim, Jane J.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (04) : 932 - 940
  • [9] Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
    Goldie, Sue J.
    O'Shea, Meredith
    Campos, Nicole Gastineau
    Diaz, Mireia
    Sweet, Steven
    Kim, Sun-Young
    [J]. VACCINE, 2008, 26 (32) : 4080 - 4093
  • [10] Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
    Bilcke, Joke
    Antillon, Marina
    Pieters, Zoe
    Kuylen, Elise
    Abboud, Linda
    Neuzil, Kathleen M.
    Pollard, Andrew J.
    Paltiel, A. David
    Pitzer, Virginia E.
    [J]. LANCET INFECTIOUS DISEASES, 2019, 19 (07): : 728 - 739
12345